These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10769083)

  • 21. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
    Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
    J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
    Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection.
    Renois F; Hong SS; Le Naour R; Gafa V; Talmud D; Andréoletti L; Lévêque N
    Virus Res; 2011 Jun; 158(1-2):46-54. PubMed ID: 21420451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
    Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
    Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of the neonatal FC receptor in the uncoating of echoviruses and coxsackievirus A9.].
    Usoltseva PS; Alimov AV; Rezaykin AV; Sergeev AG; Novoselov AV
    Vopr Virusol; 2019; 64(3):132-139. PubMed ID: 31622060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.
    Clarkson NA; Kaufman R; Lublin DM; Ward T; Pipkin PA; Minor PD; Evans DJ; Almond JW
    J Virol; 1995 Sep; 69(9):5497-501. PubMed ID: 7543583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
    Pettigrew DM; Williams DT; Kerrigan D; Evans DJ; Lea SM; Bhella D
    J Biol Chem; 2006 Feb; 281(8):5169-77. PubMed ID: 16272562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route.
    Pan J; Zhang L; Odenwald MA; Shen L; Turner JR; Bergelson JM
    J Virol; 2015 Apr; 89(8):4311-8. PubMed ID: 25653430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
    Shafren DR; Williams DT; Barry RD
    J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells.
    Kunii H; Shichishima T; Saitoh Y; Noji H; Maruyama Y
    Fukushima J Med Sci; 1998 Dec; 44(2):69-81. PubMed ID: 10091379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
    Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM
    J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic cleavage of VP1 in 'A' particles of coxsackievirus B3 does not appear to mediate virus uncoating by HeLa cells.
    McGeady ML; Crowell RL
    J Gen Virol; 1981 Aug; 55(Pt 2):439-50. PubMed ID: 6270273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
    Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
    J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.